private:icbinternational
|
2916424
|
May 29th, 2019 12:00AM
|
ICB International, Inc.
|
128
|
11.00
|
Open
|
Biotechnology
|
May 28th, 2019 09:15PM
|
May 28th, 2019 09:15PM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
Open
|
|
Open
|
505 Coast Blvd South, #405
|
La Jolla
|
CA
|
US
|
92037
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 17th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 16th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 15th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 14th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 13th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 12th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 11th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 10th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|
private:icbinternational
|
2916424
|
Feb 9th, 2018 12:00AM
|
ICB International, Inc.
|
96
|
7.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
|
|
|
|
|
|
|
|
|
|
ICB International
|
Health Care
|
Health Care Equipment & Services
|